ISSUE #19
Jan 13, 2026
π
Browse Past Issues
We launches New AD Products!
Get your brand noticed by KoreaBIO's specialized biotech audience.
From Korea's industry leaders to a global audience, all in one go!
βΌ Check out our AD solutions across our website and YouTube βΌ
Korean
/
English
Hosted Successfully!π
On
Jan 13, 2026 (Tue)
, we hosted
Global IR @JPM 2026
in San Francisco.
The event supported Korean bio companies seeking overseas expansion and global bio companies exploring opportunities in Korea.
Korea
Night@JPM
2026 follows on Jan 14!
βΆ Explore more of our recent events!
Where Korean Biotech Meets Global Opportunity
EAST-WEST BIOPHARMA SUMMIT: SEOUL 2026
March 9-11, 2026
Korean pharma firms pursue FDA approvals and U.S. sales growth
This year, a variety of Korea-made medicines are aiming to enter the United States, the world's largest pharmaceutical market.
Jan 9, 2026
Β· via [Chosun Biz]
South Korea to scale up livestock waste fuel to boost renewables by 2030
The agriculture ministry says manure-based solid fuel could power 38,000 homes annually by 2030.
Jan 13, 2026
Β· via [Eco-Business]
South Korean SMEs Turn to AI, Sales Surge 33%
AI is not just a technological introduction; it is the last bastion to breathe new life into aging factories and restart the growth engine of the Korean economy.
Jan 14, 2026
Β· via [THE CHOSUN Daily]
β Korean biotech firms aim to expand
U.S. presence
at
J.P. Morgan Healthcare Conference
- Korea JoongAng Daily
β
Highlights
from the
2026 J.P. Morgan Healthcare Conference
in San Francisco - News1
β ABL Bio receives
KRW 58.5 billion upfront payment
from Eli Lilly under licensing agreement - THE BIO
β Celltrion's Eydenzelt: How Strategic Patent Agreements Enable
U.S. and European Market
Entry in 2026 - News1
β D&D Pharmatech advances phase 2 for fatty liver drug, seeks
overseas license-out
- Chosun Biz
β Huons BioPharma Wins
China Approval
for Type A Botulinum Toxin Hutox - Hitnews
β LigaChem Biosciences secures
milestone payment
from Japan's Ono Pharmaceutical - Chosun Biz
β Samil Pharm licenses
FDA-approved
ophthalmic steroid from Formosa - KBR
β Y-Biologics signs
CDMO agreement
with WuXi Biologics for triple-target immuno-oncology therapy - THE BIO
β Korea's forest agency
opens Laos office
to scale up carbon reduction project - The Korea Herald
β South Korean industrial giant DS Dansuk
partners
with NANO Nuclear - Investing.com
β Korea's Sky Labs secures
European approva
l for ring-type blood pressure monitor - BioSpectrum Asia
β ROKIT Healthcare partners with WEGO to
enter China
skin regeneration market - Chosun Biz
β Koreaβs Healthcare and Bio Industry Reshaped by
Gene Editing and Personalized Medicine
- Global Korea Post
β Rare Medicines Once Imported by Patients to Be
Supplied Directly by Government
- The Asia Business Daily
β Curocell
nears approval
for
Korea's first
CAR-T and readies commercialization - Chosun Biz
β Korean firms
race to develop Dupixent biosimilars ahead of
2031 patent expiry
- Chosun Biz
β Rolvedon's Same-Day Chemotherapy
Solution
for Neutropenia
Revealed
- News1
β Samsung Biologics seeks
AI-powered
manufacturing solutions - The Korea Times
β SK bioscience and Sanofi
launch
MenQuadfi meningococcal
vaccine
in Korea - BioSpectrum Asia
β Growing strawberries year-round, even in desert with
Korea's smart farming
- Aju Press
β Korea's
kβbeauty
medical tourism and exports fuel corporate earnings growth - Chosun Biz
β Rokit Healthcare Supplies
Artificial Skin Organoids
to Domestic Cosmetics Company - Business Korea
π°
Join our press list
Get KoreaBIO updates
& media resources
π¬
Share Your thoughts!
How was your letter today?
βοΈ
Korean Newsletter
Daily biotech news from Korea and around the world
β in Korean
Stay connected with
everything
KoreaBIO
Watch and Join!
Explore More
KoreaBIO (Korea Biotechnology Industry Organization)
700 Daewangpangyo-ro, Bundang-gu, Seongnam-si, Gyeonggi-do, Republic of Korea
+82-31-628-0037
μμ κ±°λΆ
Unsubscribe
